Triple
T1169339
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Walter Gilbert |
E24877
|
entity |
| Predicate | coFounderOf |
P104
|
FINISHED |
| Object |
Myriad Genetics
Myriad Genetics is a biotechnology company best known for developing and commercializing genetic tests, particularly for assessing inherited cancer risk.
|
E133679
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Myriad Genetics | Statement: [Walter Gilbert, coFounderOf, Myriad Genetics]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Myriad Genetics Context triple: [Walter Gilbert, coFounderOf, Myriad Genetics]
-
A.
Genentech
Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
-
B.
National Human Genome Research Institute
The National Human Genome Research Institute is a U.S. government biomedical research organization that leads and funds research on the structure, function, and impact of the human genome.
-
C.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company specializing in the development of RNA interference (RNAi)-based therapeutics for genetically defined diseases.
-
D.
Eurofins Scientific
Eurofins Scientific is a global leader in bioanalytical testing services, specializing in food, environmental, pharmaceutical, and clinical laboratory analysis.
-
E.
Illumina
Illumina is a biotechnology company best known for developing and manufacturing advanced DNA sequencing and array-based technologies used in genomics research and clinical applications.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Myriad Genetics Triple: [Walter Gilbert, coFounderOf, Myriad Genetics]
Generated description
Myriad Genetics is a biotechnology company best known for developing and commercializing genetic tests, particularly for assessing inherited cancer risk.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Myriad Genetics Target entity description: Myriad Genetics is a biotechnology company best known for developing and commercializing genetic tests, particularly for assessing inherited cancer risk.
-
A.
Genentech
Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
-
B.
National Human Genome Research Institute
The National Human Genome Research Institute is a U.S. government biomedical research organization that leads and funds research on the structure, function, and impact of the human genome.
-
C.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company specializing in the development of RNA interference (RNAi)-based therapeutics for genetically defined diseases.
-
D.
Eurofins Scientific
Eurofins Scientific is a global leader in bioanalytical testing services, specializing in food, environmental, pharmaceutical, and clinical laboratory analysis.
-
E.
Illumina
Illumina is a biotechnology company best known for developing and manufacturing advanced DNA sequencing and array-based technologies used in genomics research and clinical applications.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a494082a7c819095004f423f294a64 |
completed | March 1, 2026, 7:31 p.m. |
| NER | Named-entity recognition | batch_69a4bce821b481908bc278a3fa7973f4 |
completed | March 1, 2026, 10:25 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ac668562788190ac5f8d081a46b2ee |
completed | March 7, 2026, 5:55 p.m. |
| NEDg | Description generation | batch_69ac67a07f28819096fcd7b767e07a63 |
completed | March 7, 2026, 6 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69ac6826ef4c81909fc077bfba22b16f |
completed | March 7, 2026, 6:02 p.m. |
Created at: March 1, 2026, 7:45 p.m.